Acelot is a development stage biopharmaceutical company focused on therapies for Alzheimer’s Disease and central nervous system disorders.

Acelot’s current drug discovery pipeline comprises several novel compound families that have been validated in a number of in-vitro assays to date.

Please contact us if you are interested in partnering for any of our projects.

1 + 2 =